Question

I am a breastfeeding mother and i want to know if it is safe to use Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)-? Is Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- safe for nursing mother and child? Does Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- extracts into breast milk? Does Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- has any long term or short term side effects on infants? Can Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- influence milk supply or can Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- decrease milk supply in lactating mothers?

Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- lactation summary

Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- usage has low risk in breastfeeding
  • DrLact safety Score for Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- usage in lactation

Anti-epileptic drug with structural properties similar to Gabapentin. Also used in the treatment of anxiety disorders, neuropathic pain and fibromyalgia. It is excreted into breast milk in small quantities as plasma levels in infants were less than 10% of maternal ones when compared to those of treated mothers. No side effects were observed in those infants. Because less experience has been published than with other drugs of the same group, alternatives that are known as safer should be considered of choice during the neonatal period or in case of preterm babies.

Answer by DrLact: About Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- usage in lactation

Very limited data indicate that amounts of Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- in breastmilk are low. If Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- Possible Effects in Breastfeeding

A study randomized pregnant women to either a single dose of Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- 150 mg (n = 45), 300 mg (n = 45), or placebo (n = 45) orally 1 hour before induction of anesthesia for an elective cesarean section to reduce postoperative analgesia requirements. Three infants of mothers in the Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)- 300 mg group had difficulty latching on for breastfeeding for 8 hours after delivery, although none were sedated.[2]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.